Do you ever look back at retro versions of modern day technology to see how far we’ve come in terms of development? Lately I’ve been doing a lot of that. As we wind down from PANIC and ramp up for ENC, I’ve been considering both our progress in NMR software capabilities and how much potential is still out there. At PANIC (Practical Applications of NMR in Industry Conference), which took place in La Jolla, California this year, NMR instrumentation was discussed in a similar context. Since its invention in the late 1940’s, NMR has become a robust analytical technique with...
In 2017 we conducted our first formal customer service oriented survey. Completed by 482 industry professionals working in pharmaceuticals, academia, agrosciences, life science, and chemicals and materials science, our survey explored satisfaction with ACD/Labs’ support, responsiveness, employee knowledge, and overall software quality. A summary of the results is presented here.
As 2017 comes to an end, Daria Thorp, President and CEO of ACD/Labs, looks back the company's 23 year history, and recounts some of its notable solutions, including ACD/Spectrus, ACD/Name and ACD/Percepta. She also discusses Luminata, ACD/labs' award winning impurity control informatics solution, which was introduced earlier this year.
Andrew Anderson reports on the 2017 AAPS Annual Conference by taking a closer look at his recent byline in Laboratory Equipment. He also introduces Joe DiMartino, ACD/Labs' newly appointed solution manager for Luminata, and previews Joe's recent Q&A with Outsourcing-Pharma.com, which discusses how QbD and impurity control management directly impact process development within pharmaceutical R&D organizations.
It’s that time of year—the leaves are falling, it’s a little cooler, I can’t decide whether to dress for my morning or evening commute, and we announce the release of a new version of ACD/Labs software—version 2017.1. This annual event is a result of the hard work of many. Most importantly, however, it is the culmination of requests of new functionality and tools by customers and partners.
Professor Marcel Jaspars, head of the Marine Biodiscovery Centre at the University of Aberdeen, and leader of the PharmaSea project, is featured in this video outlining his team's research methodologies, and their unexpected discoveries related to the treatment of Epilepsy and Alzheimer’s.
Structural Elucidations of NMR spectra, whether combined with other analytical techniques, or on their own, are akin to the challenges of the most complex cryptic crosswords—maybe the kind you find in the weekend editions of The Guardian, or The Times—but much, much tougher with some clues sometimes missing. At least that’s why I believe some of our internal experts and application scientists like the challenges of solving these “puzzles” on a regular basis.
The fascinating world of metabolite identification is something I’ve been learning a lot about recently. The process of drug discovery to drug development to meeting regulations, and the complicated (often manual) workflow. My informant is colleague, Richard Lee. An easy-going and friendly guy with a vast resource of information ranging from metabolite research to cheesy chick flicks (don’t tell him I shared the latter). Read on to learn more about his research and what we'll be discussing at ASMS 2017 this week!
PITTCON 2017 was a particularly big event for the ACD/Labs team this year because we were focused on the launch of Luminata, our new informatics solution for comprehensive impurity and characterization management. The five days we spent in Chicago were the culmination of months of hard work across the entire organization, and I’m pleased to say that the launch went off without a hitch. I had the opportunity to meet with the folks at LabTube to talk about ACD/Labs and our vision for Luminata. Watch the video in our post.
Last week, we announced updates across our suite of informatics software! These improvements deliver enhanced functionality to a number of offerings on the ACD/Spectrus and ACD/Percepta Platforms. The updates also includes the introduction of our all-new metabolite identification solution, MetaSense.